Beijing Hotgen Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Beijing Hotgen Biotech has a total shareholder equity of CN¥3.4B and total debt of CN¥7.5M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are CN¥3.6B and CN¥202.6M respectively.
Key information
0.2%
Debt to equity ratio
CN¥7.49m
Debt
Interest coverage ratio | n/a |
Cash | CN¥552.41m |
Equity | CN¥3.36b |
Total liabilities | CN¥202.56m |
Total assets | CN¥3.56b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688068's short term assets (CN¥828.2M) exceed its short term liabilities (CN¥185.0M).
Long Term Liabilities: 688068's short term assets (CN¥828.2M) exceed its long term liabilities (CN¥17.5M).
Debt to Equity History and Analysis
Debt Level: 688068 has more cash than its total debt.
Reducing Debt: 688068's debt to equity ratio has increased from 0% to 0.2% over the past 5 years.
Debt Coverage: 688068's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 688068's interest payments on its debt are well covered by EBIT.